Sangamo Therapeutics, Inc (SGMOQ) shareholders
Close on Oct 19, 2026Market cap $39.43MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Armistice Capital, LLC Joint filing with Steven Boyd (9.75%) | 40,400,067 | 9.75% | 13G (passive) | Mar 31, 2026 |
| Steven Boyd Joint filing with Armistice Capital, LLC (9.38%) | 38,860,819 | 9.38% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SGMOQ | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Nomura Asset Management International Inc. | 400,000 | 0.10% | $22.00K | – | 0.00% |
| Simplex Trading, LLC | 76,500 | 0.02% | $4.13K | New | 0.00% |
| Axiom Investment Management LLC | 25,375 | 0.01% | $1.37K | – | 0.00% |
| Flow Traders U.S. LLC | 21,532 | 0.01% | $1.00K | +34 | 0.00% |
| Heritage Investment Group, Inc. | 10,000 | 0.00% | $539 | New | 0.00% |
| Barclays PLC | 1 | 0.00% | $0 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 6 | 1M | 0.1% | 2 / 1 | 0 / 105 | 0M | 105M |
| Q1 2026 | 112 | 105M | 25.4% | 29 / 30 | 16 / 16 | 72M | 15M |
| Q4 2025 | 105 | 62M | 15.0% | 18 / 26 | 32 / 20 | 10M | 10M |
| Q3 2025 | 112 | 63M | 15.1% | 18 / 38 | 18 / 19 | 20M | 31M |
| Q2 2025 | 114 | 74M | 17.8% | 17 / 30 | 32 / 24 | 32M | 11M |
| Q1 2025 | 122 | 53M | 12.7% | 23 / 33 | 33 / 28 | 7M | 16M |
| Q4 2024 | 128 | 62M | 14.9% | 42 / 33 | 29 / 16 | 23M | 18M |
| Q3 2024 | 103 | 56M | 13.6% | 16 / 24 | 34 / 40 | 8M | 34M |
| Q2 2024 | 129 | 87M | 21.0% | 26 / 32 | 45 / 28 | 12M | 28M |
| Q1 2024 | 131 | 103M | 25.0% | 21 / 30 | 50 / 17 | 28M | 13M |
| Q4 2023 | 130 | 89M | 21.5% | 19 / 42 | 43 / 23 | 14M | 28M |
| Q3 2023 | 134 | 103M | 25.0% | 9 / 34 | 48 / 26 | 6M | 9M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
29 funds held SGMOQ in Q1 2026, 78% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of SGMOQ | Value | % of fund | As of |
|---|---|---|---|---|---|
| Nomura Healthcare Fund | 400,000 | 0.10% | $21.56K | 0.00% | Jun 30, 2026 |
| VIP Disciplined Small Cap Portfolio | 220,038 | 0.05% | $11.86K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Sandy Macrae | PRESIDENT, CEO AND DIRECTOR | 1,895,043 | 0.46% | May 27, 2026 |
| Nikunj Jain | Principal Accounting Officer | 235,292 | 0.06% | May 27, 2026 |
| Gregory D. Davis | Head of Research & Technology | 113,654 | 0.03% | May 27, 2026 |
| Nathalie Dubois-Stringfellow | SVP-CHIEF DEVELOPMENT OFFICER | 328,733 | 0.08% | May 27, 2026 |
| Scott B. Willoughby | SVP, CHIEF LEGAL OFFICER, SECY | 647,370 | 0.16% | May 27, 2026 |
| Prathyusha Duraibabu | PRINCIPAL FINANCIAL OFFICER | 660,042 | 0.16% | Jan 26, 2026 |
| Robert Carey | Director | 99,600 | 0.02% | Jun 16, 2025 |
| Margaret A. Horn | Director | 82,650 | 0.02% | Jun 16, 2025 |
| Kenneth J. Hillan | Director | 99,600 | 0.02% | Jun 16, 2025 |
| Karen L. Smith | Director | 102,100 | 0.02% | Jun 16, 2025 |
| James R. Meyers | Director | 99,600 | 0.02% | Jun 16, 2025 |
| Courtney Beers | Director | 82,650 | 0.02% | Jun 16, 2025 |
| H. Stewart Parker | Director | 112,600 | 0.03% | Jun 16, 2025 |
| John Markels | Director | 96,384 | 0.02% | Jun 16, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Sandy Macrae PRESIDENT, CEO AND DIRECTOR | May 25, 2026 | Tax withholding | −12,613 | $0.17 | $2.14K | 1,895,043 |
| Nikunj Jain Principal Accounting Officer | May 25, 2026 | Tax withholding | −1,919 | $0.17 | $326 | 235,292 |
| Gregory D. Davis Head of Research & Technology | May 25, 2026 | Tax withholding | −1,630 | $0.17 | $277 | 113,654 |
| Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | May 25, 2026 | Tax withholding | −4,036 | $0.17 | $686 | 647,370 |
| Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | May 25, 2026 | Tax withholding | −4,036 | $0.17 | $686 | 328,733 |
| Gregory D. Davis Head of Research & Technology | Apr 22, 2026 | Sale | −69,827 | $0.25 | $17.46K | 115,284 |
| Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | Apr 21, 2026 | Sale | −345,942 | $0.26 | $89.94K | 332,769 |
| Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | Feb 25, 2026 | Tax withholding | −12,354 | $0.47 | $5.81K | 651,406 |
| Sandy Macrae PRESIDENT, CEO AND DIRECTOR | Feb 25, 2026 | Tax withholding | −33,637 | $0.47 | $15.81K | 1,907,656 |
| Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | Feb 25, 2026 | Tax withholding | −12,354 | $0.47 | $5.81K | 678,711 |
| Nikunj Jain Principal Accounting Officer | Feb 25, 2026 | Tax withholding | −5,119 | $0.47 | $2.41K | 237,211 |
| Gregory D. Davis Head of Research & Technology | Feb 25, 2026 | Tax withholding | −5,119 | $0.47 | $2.41K | 185,111 |
| Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | Feb 24, 2026 | Tax withholding | −1,650 | $0.47 | $776 | 663,760 |
| Sandy Macrae PRESIDENT, CEO AND DIRECTOR | Feb 24, 2026 | Tax withholding | −5,291 | $0.47 | $2.49K | 1,941,293 |
| Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | Feb 24, 2026 | Tax withholding | −2,063 | $0.47 | $970 | 691,065 |
| Nikunj Jain Principal Accounting Officer | Feb 24, 2026 | Tax withholding | −666 | $0.47 | $313 | 242,330 |
| Gregory D. Davis Head of Research & Technology | Feb 24, 2026 | Tax withholding | −832 | $0.47 | $391 | 190,230 |
| Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | Jan 22, 2026 | Tax withholding | −36,676 | $0.40 | $14.67K | 693,128 |
| Gregory D. Davis Head of Research & Technology | Jan 22, 2026 | Tax withholding | −7,721 | $0.40 | $3.09K | 191,062 |
| Prathyusha Duraibabu PRINCIPAL FINANCIAL OFFICER | Jan 22, 2026 | Tax withholding | −36,676 | $0.40 | $14.67K | 660,042 |
| Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | Jan 22, 2026 | Tax withholding | −36,676 | $0.40 | $14.67K | 665,410 |
| Sandy Macrae PRESIDENT, CEO AND DIRECTOR | Jan 22, 2026 | Tax withholding | −102,950 | $0.40 | $41.18K | 1,946,584 |
| Nikunj Jain Principal Accounting Officer | Jan 22, 2026 | Tax withholding | −7,721 | $0.40 | $3.09K | 242,996 |
| Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | Nov 24, 2025 | Tax withholding | −2,035 | $0.42 | $855 | 702,086 |
| Prathyusha Duraibabu PRINCIPAL FINANCIAL OFFICER | Nov 24, 2025 | Tax withholding | −2,544 | $0.42 | $1.07K | 696,718 |
| Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | Nov 24, 2025 | Tax withholding | −2,544 | $0.42 | $1.07K | 719,804 |
| Sandy Macrae PRESIDENT, CEO AND DIRECTOR | Nov 24, 2025 | Tax withholding | −7,488 | $0.42 | $3.14K | 2,049,534 |
| Nikunj Jain Principal Accounting Officer | Nov 24, 2025 | Tax withholding | −578 | $0.42 | $243 | 245,717 |
| Gregory D. Davis Head of Research & Technology | Nov 24, 2025 | Tax withholding | −723 | $0.42 | $304 | 193,791 |
| Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | Oct 22, 2025 | Tax withholding | −43,741 | $0.66 | $28.87K | 722,348 |
| Nikunj Jain Principal Accounting Officer | Oct 22, 2025 | Tax withholding | −6,708 | $0.66 | $4.43K | 246,295 |
| Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | Oct 22, 2025 | Tax withholding | −44,122 | $0.66 | $29.12K | 704,121 |
| Sandy Macrae PRESIDENT, CEO AND DIRECTOR | Oct 22, 2025 | Tax withholding | −126,950 | $0.66 | $83.79K | 2,057,022 |
| Gregory D. Davis Head of Research & Technology | Oct 22, 2025 | Tax withholding | −6,708 | $0.66 | $4.43K | 194,514 |
| Prathyusha Duraibabu PRINCIPAL FINANCIAL OFFICER | Oct 22, 2025 | Tax withholding | −45,225 | $0.66 | $29.85K | 699,262 |
| Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | Aug 24, 2025 | Tax withholding | −1,434 | $0.59 | $846 | 748,243 |
| Gregory D. Davis Head of Research & Technology | Aug 24, 2025 | Tax withholding | −723 | $0.59 | $427 | 201,222 |
| Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | Aug 24, 2025 | Tax withholding | −1,792 | $0.59 | $1.06K | 744,487 |
| Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | Aug 24, 2025 | Tax withholding | −1,792 | $0.59 | $1.06K | 766,089 |
| Sandy Macrae PRESIDENT, CEO AND DIRECTOR | Aug 24, 2025 | Tax withholding | −7,488 | $0.59 | $4.42K | 2,183,972 |
| Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | Jul 22, 2025 | Tax withholding | −31,866 | $0.48 | $15.30K | 749,677 |
| Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | Jul 22, 2025 | Tax withholding | −31,866 | $0.48 | $15.30K | 746,279 |
| Sandy Macrae PRESIDENT, CEO AND DIRECTOR | Jul 22, 2025 | Tax withholding | −126,950 | $0.48 | $60.94K | 2,191,460 |
| Gregory D. Davis Head of Research & Technology | Jul 22, 2025 | Tax withholding | −6,708 | $0.48 | $3.22K | 201,945 |
| Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | Jul 22, 2025 | Tax withholding | −31,866 | $0.48 | $15.30K | 767,881 |
| H. Stewart Parker Director | Jun 12, 2025 | Award | +25,000 | – | – | 112,600 |
| Margaret A. Horn Director | Jun 12, 2025 | Award | +25,000 | – | – | 82,650 |
| Courtney Beers Director | Jun 12, 2025 | Award | +25,000 | – | – | 82,650 |
| James R. Meyers Director | Jun 12, 2025 | Award | +25,000 | – | – | 99,600 |
| Karen L. Smith Director | Jun 12, 2025 | Award | +25,000 | – | – | 102,100 |
| John Markels Director | Jun 12, 2025 | Award | +25,000 | – | – | 96,384 |
| Kenneth J. Hillan Director | Jun 12, 2025 | Award | +25,000 | – | – | 99,600 |
| Robert Carey Director | Jun 12, 2025 | Award | +25,000 | – | – | 99,600 |
| Nathalie Dubois-Stringfellow SVP-CHIEF DEVELOPMENT OFFICER | May 24, 2025 | Tax withholding | −1,792 | $0.47 | $842 | 799,747 |
| Sandy Macrae PRESIDENT, CEO AND DIRECTOR | May 24, 2025 | Tax withholding | −7,488 | $0.47 | $3.52K | 2,318,410 |
| Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | May 24, 2025 | Tax withholding | −1,792 | $0.47 | $842 | 778,145 |
| Gregory D. Davis Head of Research & Technology | May 24, 2025 | Tax withholding | −723 | $0.47 | $340 | 208,653 |
| Scott B. Willoughby SVP, CHIEF LEGAL OFFICER, SECY | May 24, 2025 | Tax withholding | −1,433 | $0.47 | $674 | 781,543 |
| Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY | Apr 22, 2025 | Tax withholding | −31,866 | $0.78 | $24.86K | 782,976 |
| Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER | Apr 22, 2025 | Tax withholding | −31,866 | $0.78 | $24.86K | 779,937 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 5 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Sangamo Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 100,088 shares on Sep 16, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Gregory D. Davis Officer | Apr 22, 2026 | 69,827 | $17.70K | Apr 22, 2026 | Restricted Stock |
| Nathalie Dubois-Stringfellow Officer | Apr 6, 2026 | 588,711 | $176.67K | Apr 6, 2026 | ESPP Purchase |
See a number that looks wrong?